en

PRODUCT DETAIL

Xarelto 2,5 mg filmom obalené tablety

Code 8109C
MA number EU/1/08/472/047
Product Form: tbl flm 14x2,5 mg (blis.PVC/PVDC/Al)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 16 - ANTICOAGULANTIA (FIBRINOLYTICA, ANTIFIBRINOL.)
ATC:
B BLOOD AND BLOOD FORMING ORGANS
B01 ANTITHROMBOTIC AGENTS
B01A ANTITHROMBOTIC AGENTS
B01AF Direct factor Xa inhibitors
B01AF01 Rivaroxaban
Shelf life: 36
Route of admin.: Oral use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 30.09.2008
SmPC + PL: European Medicines Agency's database
Dokument: Xarelto_karta_pre_pacienta_granulát.pdf  
Dokument: Xarelto_karta_pre_pacienta_tablety.pdf  
Dokument: Xarelto_prirucka_pre_predpisujuceho_lekara.pdf  
Safety feature Yes
Data update: 09.02.2021
eu-flag.png sk-flag.png